Blood sugar changes as a sign of recovery in sepsis
Part of Hormones & metabolism, Infections clinical trials.
This study looks at how blood sugar changes in patients with sepsis (a severe infection) in the intensive care unit (ICU). It aims to see if these changes can help predict how well a patient will do.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and in the ICU with sepsis (a life-threatening reaction to infection).
- You have had at least two blood sugar tests in the 6 hours before starting antibiotics.
- You will need at least three more blood sugar tests in the 24 hours after starting antibiotics.
- You have not taken steroids in the last 48 hours.
- You do not have diabetic ketoacidosis (a serious diabetes complication), hyperosmolar hyperglycemic state (very high blood sugar with dehydration), or acute pancreatitis (sudden pancreas inflammation).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a continuous glucose monitoring system (Syai Tag) in the intensive care unit (ICU). It aims to see how well it measures blood sugar levels safely compared to standard methods.
This study looks at whether a simple blood test ratio can help predict how well critically ill patients do in the intensive care unit (ICU). It aims to understand if stress-related high blood sugar affects recovery.
This study looks at whether levels of certain substances in your blood (uric acid, albumin, and lactate) can predict how well you do when you have sepsis. It might help doctors better understand your condition and guide your care in the ICU.
This study looks at whether a simple blood test can help doctors find out if ICU patients with infections are likely to develop sepsis within the next 48 hours. If you join, the researchers will measure a protein in your blood and follow you to see if you get sepsis.
This trial checks whether a continuous glucose monitoring system (“CGM GUARDIAN 2”) can be used safely and effectively for people in the ICU who have septic shock and high blood sugar. It may help the medical team track blood sugar more easily while you receive insulin.
This study looks at how the immune system changes during sepsis, a life-threatening infection that can cause organ failure. By studying blood samples over time, researchers hope to find better ways to treat or prevent complications.
Hear when a new Glucose Fluctuations in Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.